Research improves understanding of how gut bacteria affect hypertension

ddf8d0b7-1c32-4013-83ae-ad646b939d62articleimage.jpg

05 Oct 2017 --- Scientists are a step closer to identifying a mechanism to explain how gut bacteria increase blood pressure, thanks to US researchers from the University of Illinois (U of I) and Brown University. Jason Ridlon, an assistant professor in the Department of Animal Sciences at U of I, first discovered the gene for an enzyme in certain bacteria that changes cortisol, a steroid hormone, into another steroid known as an androgen.

Ridlon worked with endocrinologist David Morris at Brown and found that when bacteria break that androgen down further, the end product, a molecule called a GALF, disrupts a process that regulates sodium transport out of human kidney cells. When that happens, sodium builds up in cells, and blood pressure rises.

The news comes at a time when one in three American adults suffers from high blood pressure, or hypertension, notes the University of Illinois College of Agricultural, Consumer and Environmental Sciences (ACES) press release. The disease can be passed down in families, and certain lifestyle factors such as smoking, high-sodium diets, and stress can increase the risk.

In recent years, scientists have discovered that certain gut bacteria may contribute to hypertension as well. In a few studies, when gut bacteria were killed off with antibiotics, patients with hypertension saw a drop in blood pressure. In addition, when gut bacteria were transplanted from hypertensive people into normal mice, they developed high blood pressure.

“There are probably multiple mechanisms through which gut bacteria can affect hypertension, but this is one that needs to be pursued,” Ridlon says. He and Morris explore the idea in depth in a new article published in the journal Steroids.

Fooling the receptor
To maintain normal blood pressure, a particular receptor has to bind with a molecule called aldosterone and then move into the cell nucleus. That sparks a cascade of reactions whose end-product is a protein that manages normal sodium and potassium transport into and out of the cell. But the receptor can be fooled, binding to cortisol instead of aldosterone.

If that happens, as it does in rare individuals with a disease called apparent mineralocorticoid excess (AME), the cascade of reactions goes into hyperdrive. Sodium is imported faster than it can be exported, and the cell begins to swell into a dangerous hypertensive state.

In normal individuals, an enzyme called 11βHSD2 acts as the guardian of that receptor, keeping cortisol from binding by changing it to cortisone. GALFs – a molecule of which there are a number – stop 11βHSD2 from working. Cortisol floods the receptor binding sites and hypertension starts.

From a different research effort, Ridlon has found that not all gut bacteria metabolize cortisol in the same way, or generate GALFs.

“Two people might have the same amount of the bacterium Clostridium scindens, for example, but one person might have the type that has the pathway for generating these steroids. You can only tell by quantifying the genes, but we have to find them first,” Ridlon says.

In a recent article, published in the Journal of Lipid Research, he does just that, reporting the genes involved in GALF formation in Butyricicoccus desmolans.

“The next step is trying to see if these pathways correlate in patients that have certain forms of hypertension,” Ridlon says. “Are there higher abundances of these genes?”

The hope is that one day the research will lead to a drug therapy to combat hypertension. Ridlon says if they are better able to understand what the bacteria are doing, it would be possible to develop inhibitors of the enzymes that produce GALFs in these bacteria. “It would be great if we could find a targeted solution instead of wiping out everything with antibiotics,” he says.

Ridlon and Morris co-authored “Glucocorticoids and gut bacteria: ‘The GALF Hypothesis’ in the metagenomic era,” published in Steroids. Ridlon, Saravanan Devendran, and Celia Mendez-Garcia co-authored “Identification and characterization of a 20β-HSDH from the anaerobic gut bacterium Butyricicoccus desmolans ATCC 43058,” published in the Journal of Lipid Research.

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Health & Nutrition News

Mushrooms hold potential for prebiotic diabetes treatment, study finds

17 Aug 2018 --- Eating white button mushrooms can create subtle shifts in the microbial community in the gut, which could improve the regulation of glucose in the liver, according to a team of Penn State College of Agricultural Sciences researchers. They also suggest that better understanding this connection between mushrooms and gut microbes in mice could one day pave the way for new diabetes treatments and prevention strategies for people.

Health & Nutrition News

Coca-Cola invests in Bodyarmor, challenges Pepsi’s sports drink dominance

15 Aug 2018 --- Coca-Cola is to acquire a minority ownership stake in Bodyarmor – a fast-growing line of premium sports performance and hydration beverages – in a move that signifies Coca-Cola’s challenge to the strong market player Gatorade, which is owned by Pepsi. Financial terms of the agreement, including the size of the acquired stake, have not been disclosed.

Health & Nutrition News

Baobab resurgence? Things are looking up for the “upside down” tree

14 Aug 2018 --- The baobab superfruit has been enjoying an NPD resurgence, boosted by renewed interest in the digestive health and low GI space, as well its strong potential for use in the sports nutrition market. The superfood – which is touted as offering low GI appeal, a high dietary fiber content and for being rich in vitamin C – has seen annual growth of 53 percent, according to Innova Market Insights data. Speaking to NutritionInsight, Henry Johnson, baobab specialist at EcoProducts, details the growing array of applications for the superfood, as well as the economic ripening of the environment for market growth for baobab.

Health & Nutrition News

UK women of childbearing age falling short on key micronutrient requirements, survey finds

13 Aug 2018 --- The micronutrient intake of women in their childbearing years, as well as young people in general, fall short in key micronutrients such as magnesium and selenium. UK researchers note that improvements in dietary quality are needed in young adulthood and mid-life. Alongside this, fortification and supplementation strategies may be considered to help adults achieve dietary targets at this life-stage when they should be at their “nutritional prime.”

Health & Nutrition News

Sodium guidelines under scrutiny: Only regions consuming over 5g a day should be targeted, concludes study

10 Aug 2018 --- A new study shows that for the vast majority of communities, sodium consumption is not associated with an increase in health risks except for those whose average consumption exceeds 5g/day (equivalent to 12.5g of salt, or 2.5 teaspoons). Communities with high average levels of sodium intake (above 5g/day) were mostly seen in China, with only about 15% of communities outside China exceeding this level of consumption. 

More Articles
URL : http://www.nutritioninsight.com:80/news/research-improves-understanding-of-how-gut-bacteria-affect-hypertension.html